Takeda expands cancer business in $4.66bn deal – Independent Online

Takeda expands cancer business in .66bn deal – Independent Online

Independent OnlineTakeda expands cancer business in $4.66bn dealIndependent OnlineValeant Pharmaceuticals International had been in talks to sell its Salix gastrointestinal drugs business to Takeda, although those discussions later broke down because of disagreements over the price, Bloomberg News reported last year, citing people …Takeda is buying Ariad Pharmaceuticals in a $5.2 billion dealBusiness Insiderall 113 news articles »
Takeda expands cancer business in .66bn deal – Independent Online